Shares in Surmodics (NSDQ:SRDX) fell slightly today after the medical device maker missed expectations on Wall Street with its first quarter results.
The Eden Prairie, Minn.-based company swung to a net loss of -$1.5 million on sales of $17.0 million for the 3 months ended Dec. 31, for a sales loss of -4% compared with the same period last year.
Get the full story at our sister site, Drug Delivery Business News.
The post Surmodics misses sales estimates in Q1 appeared first on MassDevice.